miRNA Profile in Aneurysmal Subarachnoid Haemorrhage
miRNA
Circulating and CSF miRNA Profile in Patients With Acute Aneurysmal Subarachnoid Haemorrhage
1 other identifier
observational
100
1 country
1
Brief Summary
The investigators aim to investigate and understand the circulating miRNA profiles after acute aneurysmal subarachnoid haemorrhage and underlying pathological significance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 12, 2017
CompletedFirst Posted
Study publicly available on registry
November 17, 2017
CompletedStudy Start
First participant enrolled
November 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2023
CompletedSeptember 7, 2023
September 1, 2023
5.8 years
October 12, 2017
September 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Circulating micro RNA concentrations
Serum micro RNA concentrations
Day 3
Secondary Outcomes (3)
Circulating micro RNA change
Days 1,2,3,7
Cerebrospinal fluid micro RNA concentrations
Day 1,2,3,7
Cerebrospinal fluid micro RNA change
Days 1,2,3,7
Study Arms (3)
SAH with DCI
Aneurysmal subarachnoid haemorrhage patients with delayed cerebral infarction
SAH nonDCI
Aneurysmal subarachnoid haemorrhage patients without delayed cerebral infarction
Control
Healthy volunteers
Eligibility Criteria
* Acute aneurysmal subarachnoid hemorrhage patients with and without delayed cerebral infarction * Healthy volunteers
You may qualify if:
- Aneurysmal subarachnoid hemorrhage patients within the first 72 hours or Healthy volunteers
You may not qualify if:
- Previous neurological diseases such as stroke or dementia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Surgery, The Chinese University of Hong Kong
Hong Kong, China
Related Publications (3)
Lu G, Wong MS, Xiong MZQ, Leung CK, Su XW, Zhou JY, Poon WS, Zheng VZY, Chan WY, Wong GKC. Circulating MicroRNAs in Delayed Cerebral Infarction After Aneurysmal Subarachnoid Hemorrhage. J Am Heart Assoc. 2017 Apr 25;6(4):e005363. doi: 10.1161/JAHA.116.005363.
PMID: 28442458BACKGROUNDSu XW, Chan AH, Lu G, Lin M, Sze J, Zhou JY, Poon WS, Liu Q, Zheng VZ, Wong GK. Circulating microRNA 132-3p and 324-3p Profiles in Patients after Acute Aneurysmal Subarachnoid Hemorrhage. PLoS One. 2015 Dec 16;10(12):e0144724. doi: 10.1371/journal.pone.0144724. eCollection 2015.
PMID: 26675167BACKGROUNDWong GK, Lam S, Ngai K, Wong A, Mok V, Poon WS; Cognitive Dysfunction after Aneurysmal Subarachnoid Haemorrhage Investigators. Evaluation of cognitive impairment by the Montreal cognitive assessment in patients with aneurysmal subarachnoid haemorrhage: prevalence, risk factors and correlations with 3 month outcomes. J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1112-7. doi: 10.1136/jnnp-2012-302217. Epub 2012 Jul 31.
PMID: 22851612BACKGROUND
Biospecimen
Serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
George KC Wong
Chinese University of Hong Kong
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor(Clinical)
Study Record Dates
First Submitted
October 12, 2017
First Posted
November 17, 2017
Study Start
November 30, 2017
Primary Completion
August 31, 2023
Study Completion
August 31, 2023
Last Updated
September 7, 2023
Record last verified: 2023-09